CDK4 and neoplasm: In non–small‐cell lung cancer, miR‐134 inhibited the expression of cyclin D1/2 and cyclin‐dependent kinase 4 by up‐regulating the expression of P21, thereby inhibiting the proliferation of tumour cells.24